Testing HJB647 low dose against a placebo for heart failure with reduced ejection fraction
Explore this study →
One site, in Montreal
Official title: A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Heart Failure With Reduced Ejection Fraction · Novartis Pharmaceuticals